June 14, 2018
Verastem Oncology (VSTM) a registered stock sale
April 4, 2018
Cellectis (CLLS) prices follow-on $175 M ADS offering
February 7, 2018
Adverum Biotechnologies (ADVM) closed $69 M offering
January 22, 2018
Stemline Therapeutics (STML) proposes 3.7 M share offering
January 16, 2018
Intrexon (XON) Prices 6 M share offering at $12.50
December 19, 2017
Northwest Bio (NWBO) Just another Ponzi financing scheme
December 14, 2017
Verastem (VSTM) proposes $25 M offering
December 13, 2017
Fate Therapeutics (FATE) closes $42.9 M offering at $4.20
December 12, 2017
bluebird bio (BLUE) Prices 3.343 M share offering at $185.00
December 4, 2017
Northwest Biotherapeutics (NWBO) completed a $12 M financing
November 28, 2017
Cesca Therapeutics (KOOL) proposes 900 K share offering priced at $3.00
November 16, 2017
AxoGen (AXGN) Prices offering of 2 M share at $21.00
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at firstname.lastname@example.org.
Editor and Publisher ... Henry McCusker enters his thirteenth (13th) year at RegMed Investors